FR2806262A1 - Nutritional supplement for protection against premenstrual symptoms, menopausal problems, osteoporosis, and cancers comprises evening primrose and borage oils - Google Patents
Nutritional supplement for protection against premenstrual symptoms, menopausal problems, osteoporosis, and cancers comprises evening primrose and borage oils Download PDFInfo
- Publication number
- FR2806262A1 FR2806262A1 FR0003463A FR0003463A FR2806262A1 FR 2806262 A1 FR2806262 A1 FR 2806262A1 FR 0003463 A FR0003463 A FR 0003463A FR 0003463 A FR0003463 A FR 0003463A FR 2806262 A1 FR2806262 A1 FR 2806262A1
- Authority
- FR
- France
- Prior art keywords
- nutritional supplement
- vitamin
- evening primrose
- prostaglandins
- osteoporosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 235000015872 dietary supplement Nutrition 0.000 title claims abstract description 12
- 235000007689 Borago officinalis Nutrition 0.000 title claims abstract description 4
- 239000003921 oil Substances 0.000 title abstract description 5
- 241000219925 Oenothera Species 0.000 title abstract description 3
- 235000004496 Oenothera biennis Nutrition 0.000 title abstract description 3
- 206010028980 Neoplasm Diseases 0.000 title description 5
- 241001072256 Boraginaceae Species 0.000 title description 3
- 208000001132 Osteoporosis Diseases 0.000 title description 3
- 208000024891 symptom Diseases 0.000 title 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims abstract description 14
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 7
- 239000011709 vitamin E Substances 0.000 claims abstract description 7
- 229930003316 Vitamin D Natural products 0.000 claims abstract description 6
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 6
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 6
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 6
- 229930195729 fatty acid Natural products 0.000 claims abstract description 6
- 239000000194 fatty acid Substances 0.000 claims abstract description 6
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000019166 vitamin D Nutrition 0.000 claims abstract description 6
- 239000011710 vitamin D Substances 0.000 claims abstract description 6
- 229940046009 vitamin E Drugs 0.000 claims abstract description 6
- 229940046008 vitamin d Drugs 0.000 claims abstract description 6
- 150000003710 vitamin D derivatives Chemical class 0.000 claims abstract description 4
- 240000004355 Borago officinalis Species 0.000 claims abstract 2
- 229940094443 oxytocics prostaglandins Drugs 0.000 claims description 9
- 150000003180 prostaglandins Chemical class 0.000 claims description 9
- 244000163122 Curcuma domestica Species 0.000 claims description 6
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 5
- 235000003373 curcuma longa Nutrition 0.000 claims description 5
- 239000010475 evening primrose oil Substances 0.000 claims description 5
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 claims description 5
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 235000013976 turmeric Nutrition 0.000 claims description 5
- 229940088594 vitamin Drugs 0.000 claims description 5
- 229930003231 vitamin Natural products 0.000 claims description 5
- 235000013343 vitamin Nutrition 0.000 claims description 5
- 239000011782 vitamin Substances 0.000 claims description 5
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 230000003078 antioxidant effect Effects 0.000 claims description 3
- 235000006708 antioxidants Nutrition 0.000 claims description 3
- 235000020664 gamma-linolenic acid Nutrition 0.000 claims description 3
- 229960002733 gamolenic acid Drugs 0.000 claims description 3
- 230000003211 malignant effect Effects 0.000 claims description 3
- 238000003786 synthesis reaction Methods 0.000 claims description 3
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 3
- 206010036618 Premenstrual syndrome Diseases 0.000 claims description 2
- 239000002243 precursor Substances 0.000 claims description 2
- 208000011580 syndromic disease Diseases 0.000 claims description 2
- 230000009245 menopause Effects 0.000 claims 3
- 230000007812 deficiency Effects 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 239000013598 vector Substances 0.000 claims 1
- 235000014375 Curcuma Nutrition 0.000 abstract description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 abstract description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 abstract description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract description 2
- 229960004488 linolenic acid Drugs 0.000 abstract description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 abstract description 2
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 12
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 11
- 235000012661 lycopene Nutrition 0.000 description 11
- 239000001751 lycopene Substances 0.000 description 11
- 229960004999 lycopene Drugs 0.000 description 11
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 235000019154 vitamin C Nutrition 0.000 description 5
- 239000011718 vitamin C Substances 0.000 description 5
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 235000008524 evening primrose extract Nutrition 0.000 description 4
- 229940089020 evening primrose oil Drugs 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 235000019160 vitamin B3 Nutrition 0.000 description 4
- 239000011708 vitamin B3 Substances 0.000 description 4
- 206010006187 Breast cancer Diseases 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 241000227653 Lycopersicon Species 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 235000019158 vitamin B6 Nutrition 0.000 description 3
- 239000011726 vitamin B6 Substances 0.000 description 3
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 229930003537 Vitamin B3 Natural products 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 230000001028 anti-proliverative effect Effects 0.000 description 2
- 230000002225 anti-radical effect Effects 0.000 description 2
- 235000021324 borage oil Nutrition 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940098330 gamma linoleic acid Drugs 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- GMRQFYUYWCNGIN-UHFFFAOYSA-N 1,25-Dihydroxy-vitamin D3' Natural products C1CCC2(C)C(C(CCCC(C)(C)O)C)CCC2C1=CC=C1CC(O)CC(O)C1=C GMRQFYUYWCNGIN-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 101000692460 Bos taurus Prostaglandin F synthase 1 Proteins 0.000 description 1
- 206010006313 Breast tenderness Diseases 0.000 description 1
- 206010014733 Endometrial cancer Diseases 0.000 description 1
- 206010014759 Endometrial neoplasm Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 241000219929 Onagraceae Species 0.000 description 1
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003217 anti-cancerogenic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229960005084 calcitriol Drugs 0.000 description 1
- GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 description 1
- 235000012682 canthaxanthin Nutrition 0.000 description 1
- 239000001659 canthaxanthin Substances 0.000 description 1
- 229940008033 canthaxanthin Drugs 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000006369 cell cycle progression Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 229940069752 halibut liver oil Drugs 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000020082 intraepithelial neoplasia Diseases 0.000 description 1
- 230000005741 malignant process Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
NOUVEAU COMPLEMENT NUTRITIONNEL A BASE DE LYCOPENE DE TOMATE, D'HUILES D'ONAGRE, DE BOURRACHE. D'UN COMPLEXE MULTIVITAMINIQVE ET DE CURCUMA. La présente invention concerne une formulation renfermant des nutriments apportant à l'organisme humain une protection. Cette protection concerne aussi bien la femme pré ménopausée que post ménopausée. NEW NUTRITIONAL SUPPLEMENT BASED ON LYCOPENE TOMATO, OIL ONAGRE, BOURRACHE. MULTIVITAMINIC COMPLEX AND CURCUMA. The present invention relates to a formulation containing nutrients providing the human body with protection. This protection concerns both pre-menopausal and post-menopausal women.
Elle a plus particulièrement pour objet d'apporter à l'organisme humain un complexe huileux riche en acides gras de la série S2 6, du lycopène de tomate, de Ici vitamine E, C, B3, ô6 ainsi que des actifs naturels possédant des propriétés contre la prolifération cellulaire. It is more particularly intended to provide the human body with an oily complex rich in fatty acids of the S2 6 series, tomato lycopene, Vitamin E, C, B3 and O6, as well as natural active ingredients possessing properties against cell proliferation.
D'une manière générale, les formulations utilisant des phytonutriments utilisés en supplémentation alimentaire, et ayant pour but d'apporter les acides gras gamma linoléiques ne renferment pas de vitamines C, B3 et B6. In general, formulations using phytonutrients used in food supplementation and intended to provide gamma linoleic fatty acids do not contain vitamins C, B3 and B6.
L'originalité de cette formulation réside dans le fait qu'elle apporte l'acide gras gamma linoléique (GLA) avec les vitamines qui permettent à l'organisme de synthétiser les prostaglandines PG E1 et PGF 1 a. The originality of this formulation lies in the fact that it brings gamma linoleic fatty acid (GLA) with the vitamins that allow the body to synthesize the PG E1 and PGF 1 a prostaglandins.
Cette formulation renferme un nutriment qui a pour rôle de protéger contre les radicaux libres. Il est aussi protecteur contre les syndromes malins : le lycopène de tomate. This formulation contains a nutrient whose role is to protect against free radicals. It is also protective against malignant syndromes: tomato lycopene.
La vitamine D, dans ce supplément nutritionnel, possède un double rôle : elle coopère avec le lycopène contre les processus malins et permet de renforcer la charpente osseuse en fixant le calcium et le phosphore alimentaires, prévenant contre l'ostéoporose. Vitamin D, in this nutritional supplement, has a dual role: it cooperates with lycopene against malignant processes and helps strengthen the bone structure by fixing dietary calcium and phosphorus, preventing against osteoporosis.
Le curcuma possède aussi une action sur les cellules cancéreuses : il est protecteur. Turmeric also has an action on cancer cells: it is protective.
INGREDIENTS <B><U>Le</U></B> 1ycopène <B><U>de tomate</U></B> est un excellent anti-radicaux libres et protecteur contre certaines pathologies malignes. Le lycopène piège les radicaux libres et participe à la lutte contre la formation de peroxydes toxiques pour l'organisme. I) agit beaucoup plus efficacement que les autres caroténdides dans le processus d'antioxydation. INGREDIENTS <B> <U> </ B> </ B> </ B> </ B> 1 </ b> Tomato ycopene <B> </ B> </ B> is an excellent anti-free radicals and protective against certain malignant diseases. Lycopene traps free radicals and helps fight against the formation of toxic peroxides for the body. I) acts much more effectively than other carotenes in the process of antioxidation.
Plusieurs rapports scientifiques ont démontré l'effet du lycopène dans la protection contre les cancers du sein et de l'utérus chez la femme. Les femmes qui possèdent un taux sérique élevé de lycopène sont mieux protégées contre le cancer du sein et de l'endomètre. Several scientific reports have demonstrated the effect of lycopene in the protection against breast and uterine cancers in women. Women with high serum lycopene levels are better protected against breast and endometrial cancer.
NAGASAWA, <I><U>H. et al,</U></I> Effects <I>of</I> lycopene <I>on</I> spontaneous mammary tumor in 5HN virgin mice. <B><I>A</I></B><I>n</I> ticancer Res, <I>15: 1173-1178, 1995)</I> PALAN <I><U>P. R and al.</U> Plasma</I> level <I>of<B>6</B></I> carotene, Lycopene, Canthaxanthin, Retinol, <I>and</I> Tocopherol <I>in Cervical</I> Intraepithelial Neoplasia <I>and</I> Cancer. NAGASAWA, <i> <u> H. et al, </ i> </ i> Effects <i> of </ i> lycopene <I> one </ i> spontaneous mammary tumor in 5HN virgin mice. <B> <I> A </ I> </ B> <I> n </ I> ticancer Res, <I> 15: 1173-1178, 1995) </ I> PALAN <I> <U> P. R et al. </ U> Plasma </ i> level <I> of <B> 6 </ i> carotene, Lycopene, Canthaxanthin, Retinol, <i> and </ I> Tocopherol <I> in Cervical </ I> Intraepithelial Neoplasia <I> and </ I> Cancer.
Clinical <I>Cancer Research. Vol 2, 181-185 (1996)</I> sENSUPTA <I><U>A and a</U>l. The</I> anti=carcinogenic role <I>of</I> lycopene, abundantly present <I>in</I> tomato. Eur. <I>J. Cancer</I> Pre <I>v.. 8, (4) : 325-330 (1999)</I> <B>L'huile de bourrache</B> riche en acides gras essentiels, elle renferme 22 fo d'acide gamma linoléique. Elle assure une hydratation intense de la peau et permet de lutter contre le dessèchement cutané et d'optimiser le métabolisme cellulaire. Clinical <I> Cancer Research. Vol 2, 181-185 (1996) </ I> SENSUPTA <I> <U> A and a </ U> l. The </ I> anti-carcinogenic role <i> of </ i> lycopene, abundantly present <i> in </ i> tomato. Eur. <I> J. Cancer </ I> Pre <I> v. 8, (4): 325-330 (1999) </ I> <B> Borage oil </ B> rich in essential fatty acids, it contains 22% of gamma linoleic acid. It ensures intense hydration of the skin and helps fight against skin dryness and optimize cellular metabolism.
Cette huile est précieuse quant à son action contre le vieillissement de la peau et la formation des rides. This oil is precious for its action against the aging of the skin and the formation of wrinkles.
<B>L'huile d'onagre</B> est riche en acide gamma linolénique (série des oméga 6) à l'origine de prostaglandines physiologiquement active. <B> Evening primrose oil </ B> is rich in gamma-linolenic acid (omega-6 series), which is the origin of physiologically active prostaglandins.
Elle régule l'action des hormones sexuelles, le maintien de l'élasticité des organes et hutte contre le vieillissement. Elle a une action sur l'irritabilité, les troubles dû à la menstruation et les risques cardio-vasculaires. It regulates the action of sex hormones, maintaining the elasticity of organs and hut against aging. It has an action on irritability, disorders due to menstruation and cardiovascular risks.
L'huile d'onagre est administrée comme précurseur de prostaglandines de par son contenu en acide gamma linolénique. bes études ont montré que l'huile d'onagre régule le système hormonal. Prise pendant la deuxième moitié du cycle menstruel, elle diminue nettement le syndrome prémenstruel en agissant sur toutes ses manifestations : dépression, irritabilité, tension mammaire, douleurs abdominales, rétention d'eau et céphalées. Evening primrose oil is administered as a precursor of prostaglandins by its content in gamma linolenic acid. Studies have shown that evening primrose oil regulates the hormonal system. Taken during the second half of the menstrual cycle, it significantly reduces premenstrual syndrome by acting on all its manifestations: depression, irritability, breast tenderness, abdominal pain, water retention and headache.
<B>Vitamine E</B> ou a,-tocophérol est nécessaire à l'activité de plusieurs enzymes. C'est un excellent antioxydant et inhibiteur de Ici formation de nitrosamines. La vitamine E aide à lutter contre le vieillissement cutané. <B> Vitamin E </ B> or a, -tocopherol is necessary for the activity of several enzymes. It is an excellent antioxidant and inhibitor of nitrosamine formation. Vitamin E helps fight against skin aging.
<B><U>Le complexe</U></B> vitaminé <B><U>C. B3 et B6</U></B> Les vitamines B3 et B6 et C sont nécessaires à Ici synthèse des prostaglandines bénéfiques. En effet, sans leurs concours, les enzymes qui transforment les GLA en prostaglandines sont inactives. La vitamine B6 est nécessaire à la transformation de l'acide gamma linoléique, apporté par les huiles d'onagre et de bourrache, en acide dihommo linolénique. <B> <U> The complex </ U> </ B> vitamin <B> <U> C. B3 and B6 Vitamins B3 and B6 and C are needed for synthesis of beneficial prostaglandins. Indeed, without their help, the enzymes that transform GLA into prostaglandins are inactive. Vitamin B6 is necessary for the transformation of gamma linoleic acid, provided by evening primrose and borage oils, into dihommo linolenic acid.
Les vitamines C et<B>83</B> participent ensuite à la synthèse de prostaglandines (PGE 1 et PGF 1 a) La Vitamine C est par excellence la vitamine réductrice agissant dans les phénomènes d'oxydoréduction cellulaires, elle possède un pouvoir anti asthénique et protège les vitamines A et E de l'oxydation. Vitamins C and <B> 83 </ B> then participate in the synthesis of prostaglandins (PGE 1 and PGF 1a) Vitamin C is par excellence the reducing vitamin acting in cellular redox phenomena, it has an anti asthenic and protects vitamins A and E from oxidation.
<B><U>La Vitamine b</U></B> : est apportée par l'huile de foie de flétan. Des travaux effectués sur des cultures cellulaires cancéreuses, ont démontré que la synergie lycopène - vitamine D inhibe la multiplication des cellules cancéreuses. <B> <U> Vitamin B </ U> </ B>: is brought by halibut liver oil. Work carried out on cancerous cell cultures has shown that lycopene - vitamin D synergy inhibits the multiplication of cancer cells.
AMIR H <B><U>and al</U>.</B> Lycopene and 1,25-Dihydroxyvitamin D3 cooperate in the inhibition of cell cycle progression and induction of differentiation in HL-60 leukemic cells. AMIR H <B> <U> et al </ U>. </ B> Lycopene and 1,25-Dihydroxyvitamin D3 cooperate in the inhibition of cell cycle progression and induction of differentiation in HL-60 leukemic cells.
<I>Nutrition and Cancer Research. 33 (I), 105 -112 (1999)</I> De plus, La vitamine D renforce l'action du calcium alimentaire et prévient de l'ostéoporose. <I> Nutrition and Cancer Research. 33 (I), 105 -112 (1999) </ I> In addition, vitamin D enhances the action of dietary calcium and prevents osteoporosis.
<U>Le curcuma</U> Le curcuma, très connu en Inde, possède des propriétés anti- prolifératives.
<U>Le sélénium ;</U> est un antioxydant, et est doté d'activités anti cancéreuses. RECAPITULATIF ET DOSAGES 1) Les molécules directement antiradicalaires (piégeurs <U>)</U> - Lycopène naturel de tomate (1 à 10 mg) - vitamine E (2 à 15 mg) - vitamine C (20 à 80 mg) - vitamine B3 (2 à 30 mg) - vitamine Bb (2 à 15 mg) <U>2) Les molécules venant renforcer les systèmes</U> enzymatiques <U>de défense</U> antiradicalaire. <U> Turmeric </ U> Turmeric, well known in India, has anti-proliferative properties.
<U>Selenium;</U> is an antioxidant, and has anti-cancer activities. SUMMARY AND ASSAYS 1) The molecules directly antiradical (scavengers <U>) </ U> - Lycopene natural tomato (1 to 10 mg) - vitamin E (2 to 15 mg) - vitamin C (20 to 80 mg) - vitamin B3 (2 to 30 mg) - vitamin Bb (2 to 15 mg) <U> 2) Molecules that strengthen the <U> antiradical defense </ U> enzymatic systems.
- sélénium ( 20 à 100 mcg) <U>3) Les</U> ingrédients apportant <U>l'acide gras gamma linoléique.</U> - Huile de bourrache (20 à 500 mg) - huile d'onagre (20 à 500 mg) <U>4) les ingrédients à</U> activité anti proliférative <U>cellulaire</U> - le curcuma (1 à 50 mg) - la vitamine D (2 à 50 pg) selenium (20 to 100 mcg) <U> 3) </ U> ingredients supplying <U> gamma linoleic fatty acid. </ U> - Borage oil (20 to 500 mg) - evening primrose oil ( 20 to 500 mg) <U> 4) <U> U </ U> anti-proliferative activity - Turmeric (1 to 50 mg) - Vitamin D (2 to 50 μg)
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0003463A FR2806262A1 (en) | 2000-03-17 | 2000-03-17 | Nutritional supplement for protection against premenstrual symptoms, menopausal problems, osteoporosis, and cancers comprises evening primrose and borage oils |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0003463A FR2806262A1 (en) | 2000-03-17 | 2000-03-17 | Nutritional supplement for protection against premenstrual symptoms, menopausal problems, osteoporosis, and cancers comprises evening primrose and borage oils |
Publications (1)
Publication Number | Publication Date |
---|---|
FR2806262A1 true FR2806262A1 (en) | 2001-09-21 |
Family
ID=8848224
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0003463A Withdrawn FR2806262A1 (en) | 2000-03-17 | 2000-03-17 | Nutritional supplement for protection against premenstrual symptoms, menopausal problems, osteoporosis, and cancers comprises evening primrose and borage oils |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2806262A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003068200A2 (en) * | 2002-02-15 | 2003-08-21 | Touche Marie-Jose | Novel therapeutic application for a composition |
WO2004103388A2 (en) * | 2003-05-22 | 2004-12-02 | Bioniche Life Sciences Inc. | Insect repellent |
WO2005092355A1 (en) * | 2004-03-26 | 2005-10-06 | Velez-Rivera Hector | Phyto-composition for the treatment of articular diseases |
EP1618800A1 (en) * | 2004-07-24 | 2006-01-25 | Cognis IP Management GmbH | Active compositions comprising lycopene, cytidin and fatty acids |
EP2808026A1 (en) | 2013-05-31 | 2014-12-03 | Ems S.A. | Composition for treatment or reduction of symptoms related to premenstrual syndrome (pms), premenstrual disphoric disorder (pmdd), premenopause, menopause or female hormonal disorders in a pharmaceutical composition containing said form, and process for producing said pharmaceutical form and use of said composition |
-
2000
- 2000-03-17 FR FR0003463A patent/FR2806262A1/en not_active Withdrawn
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2836046A1 (en) * | 2002-02-15 | 2003-08-22 | Marie Jose Touche | NOVEL THERAPEUTIC APPLICATION OF COMPOUND A: BUTOFORM OR SCUROFORM ASSOCIATED WITH PRODUCT B: EUGENOL AND PRODUCT C: ZINC OXIDE, ADDED TO LYCOPENE |
WO2003068200A3 (en) * | 2002-02-15 | 2004-03-25 | Marie-Jose Touche | Novel therapeutic application for a composition |
WO2003068200A2 (en) * | 2002-02-15 | 2003-08-21 | Touche Marie-Jose | Novel therapeutic application for a composition |
US7381431B2 (en) | 2003-05-22 | 2008-06-03 | Bioniche Life Sciences, Inc. | Insect repellent |
WO2004103388A2 (en) * | 2003-05-22 | 2004-12-02 | Bioniche Life Sciences Inc. | Insect repellent |
WO2004103388A3 (en) * | 2003-05-22 | 2005-04-07 | Bioniche Life Sciences Inc | Insect repellent |
US7985432B2 (en) | 2003-05-22 | 2011-07-26 | Bioniche Life Sciences, Inc. | Insect repellent |
AU2004241797B2 (en) * | 2003-05-22 | 2011-03-17 | Bioniche Life Sciences Inc. | Insect repellent |
US7595069B2 (en) | 2004-03-26 | 2009-09-29 | Hector Velez-Rivera | Phyto-composition for the treatment of joint diseases |
ES2298087A1 (en) * | 2004-03-26 | 2008-05-01 | Hector Velez-Rivera | Phyto-composition for the treatment of articular diseases |
WO2005092355A1 (en) * | 2004-03-26 | 2005-10-06 | Velez-Rivera Hector | Phyto-composition for the treatment of articular diseases |
EP1618800A1 (en) * | 2004-07-24 | 2006-01-25 | Cognis IP Management GmbH | Active compositions comprising lycopene, cytidin and fatty acids |
EP2808026A1 (en) | 2013-05-31 | 2014-12-03 | Ems S.A. | Composition for treatment or reduction of symptoms related to premenstrual syndrome (pms), premenstrual disphoric disorder (pmdd), premenopause, menopause or female hormonal disorders in a pharmaceutical composition containing said form, and process for producing said pharmaceutical form and use of said composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Souyoul et al. | Nutraceuticals: a review | |
CA2657748C (en) | Pharmaceutical and nutraceutical products comprising vitamin k2 | |
Fauziya et al. | Papaya (Carica papaya): Source material for anticancer | |
Szyszkowska et al. | The influence of selected ingredients of dietary supplements on skin condition | |
RU2317099C1 (en) | Therapeutic agent for treatment of sex dysfunction, method for production of wheat germ oil and method for production of wheat germ oil concentrate for treatment of sex function disturbances | |
FR2860976A1 (en) | Use of oral synergistic composition for treating e.g. cerebral or cardiac dysfunction, contains omega-3 fatty acids, at least two vitamins and at least two trace elements | |
CN105283190A (en) | A marine oil formulation comprising reservatrol or derivatives thereof for use in treating, delaying and/or preventing alzheimer's desease | |
FR2806262A1 (en) | Nutritional supplement for protection against premenstrual symptoms, menopausal problems, osteoporosis, and cancers comprises evening primrose and borage oils | |
EP3135281B1 (en) | Composition for preventing or improving peripheral neuropathy | |
RU2245358C2 (en) | Method for production of oil enriched in fatty hydroxyoctadecadienic acids (hode) or esters thereof from oil mixture containing linoleic acid or esters thereof | |
WO2010056318A2 (en) | Nutritional supplement | |
JP2017520606A (en) | Composition containing turkey oil | |
FR2770975A1 (en) | Food supplement which can relieve both menstrual and prostate disorders contains e.g. evening primrose and marrow seed oils and tomato lycopene | |
FR2612396A1 (en) | SKIN REGENERATING COSMETIC COMPOSITIONS AND PROCESS FOR PREPARING THE SAME | |
JP2016079154A (en) | Skin cosmetic, hair cosmetic, and food and drink | |
EP0564804A1 (en) | Improved high protein liquid nutrition for patients with elevated wound healing requirements | |
RU2350125C1 (en) | Dietary supplement | |
FR2806263A1 (en) | Nutritional supplement for protection against prostate disorders, osteoporosis, and cancers comprises squash seed oil | |
FR2894776A1 (en) | FOOD SUPPLEMENT BASED ON GROUP B VITAMINS, OLIGO-ELEMENTS AND FATTY ACIDS IN W-3 AND / OR W-6 AND THE USE OF THIS SUPPLEMENT IN THE SIMULTANEOUS TREATMENT OF LOCALIZED CELLULITE AND CUTANEOUS RELEASE | |
KR20150019562A (en) | Composition for skin cell regeneration, anti-wrinkle, antioxidant, anti-imflamation, and skin whitening | |
KR20150019566A (en) | Composition for skin cell regeneration, anti-wrinkle, antioxidant, anti-imflamation, and skin whitening | |
WO2017009870A1 (en) | A topical formulation for chronic skin and hair disease | |
KR101988907B1 (en) | Composition for skin cell regeneration, anti-wrinkle, antioxidant, anti-imflamation, and skin whitening | |
KR101999698B1 (en) | Composition for skin cell regeneration, anti-wrinkle, antioxidant, anti-imflamation, and skin whitening | |
US20220305068A1 (en) | Antiproliferative effect of agarophyton chilensis extract in prostate cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |